Posted inBiotechnology
DNER Protein Drives HSCR: Multi-Omics Reveal Insight
Hirschsprung disease (HSCR) remains one of the most enigmatic congenital disorders in pediatric medicine, its pathogenesis intricately linked to the…
Posted inBiotechnology
Study Links NSUN6 Gene Variations to Neuroblastoma Risk in Children from Jiangsu Province
In a groundbreaking case-control study focused on pediatric oncology, researchers from Jiangsu Province have unearthed compelling evidence linking specific polymorphisms…
Posted inGenetics
Samsung Joins CEPI Vaccine Network to Prepare for Next Pandemic
Samsung Biologics will develop a “ready-to-activate” vaccine manufacturing process that can be deployed during health emergencies, under a new agreement…
Posted inGenetics
Fermenter-Extractor-Separator Mixes Uniformly and Is Gentle on Cells
A combined fermenter-extractor-separator has been developed by researchers at Iowa State University. Because it uses the Taylor vortex design, it…
Posted inGenetics
Autonomy and Accountability in Bioprocessing
Artificial intelligence (AI) is moving from offline analysis into the laboratory itself, reshaping how experiments are designed, executed, and interpreted.…
Posted inGenetics
Bridging the Translation Gap for Regenerative Tissues
A muscle-tissue engineering company is set to highlight the steps being taken to ease the path of regenerative therapies into…
Posted inGenetics
Omics in Orlando: A Video Report from AGBT, Day One
As the first day of AGBT came to a close, Julianna LeMieux, PhD, Deputy Editor in Chief, chatted with Kevin…
Posted inBiotechnology
Asahi Kasei scoops up Germany’s Aicuris for $920M in R&D portfolio boost
Asahi Kasei has unveiled plans to acquire Aicuris in a deal worth 780 million euros ($920 million), marking the latest…
Posted inBiotechnology
Prenatal Factors Linked to Childhood Autism Diagnosis
In a groundbreaking development within the field of developmental neurobiology, a recent study published in Pediatric Research has provided fresh…
Posted inResearch
Charles River sells manufacturing and discovery businesses to fulfill promised pivot
After promising to sell off 7% of its business back in November, Charles River Laboratories has delivered. The CRO is…